食管癌浸润深度相关危险因素分析

doi:10.3969/j.issn.1006-6233.2021.03.017

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1487 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To study the related risk factors inherent in the invasive depth of esophageal cancer,and provide a more accurate method to judge the invasive depth of esophageal cancer. Methods: A total of 174 patients (174 lesions) diagnosed with esophageal cancer via gastroscopy and pathological diagnosis in the Second Affiliated Hospital of Zhengzhou University from June 2014 to June 2020,including 102 males (58.6%),72 females (41.4%),were retrospectively analyzed. The age,gender,tumor location,tumor size,preoperative PLR,NLR,LMR and postoperative pathological diagnosis were observed and recorded. Results: High PLR was significantly correlated with the depth of invasion (> SM1 vs ≤SM1:OR=1.017,95% CI=1.006 ~ 1.028,P = 0.002); tumor length was significantly correlated with the depth of invasion (> SM1 vs ≤SM1:OR=1.581,95% CI=1.234 ~ 2.024,P<0.001),where AUC was 0.74 and 0.796. The sensitivity was 0.495 and 0.722,and the specificity respectively was 0.883 and 0.714. The AUC,sensitivity and specificity of PLR combined with tumor length was 0.812,0.866 and 0.61. Conclusion: PLR and tumor length are accurate in their diagnostic capabilities for the depth of the invasion of esophageal cancer,and their combination can further improve accuracy and provide a more reliable basis for treatment options.

Key words： Esophageal cancer PLR Tumor length Depth of invasion

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	DING Dandan
	ZHOU Yingfa
	HUANG Linkai

Cite this article:

DING Dandan,ZHOU Yingfa,HUANG Linkai. An Analysis of Risk Factors Related to the Depth of Invasion in Esophageal Carcinoma[J]. HeBei Med, 2021, 27(3): 436-439.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2021.03.017 OR http://www.hbyxzzs.cn/EN/Y2021/V27/I3/436

[1] Bray F,Ferlay J,Soerjomataram I,et a1.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer Clin,2018,68(6):394~422.
[2] Thrumurthy SG,Chaudry MA,Thrumurthy SSD,et al.Oesophageal cancer:risks,pre-vention,and diagnosis[J].BMJ,2019,366:l4373.
[3] 中华医学会消化内镜学分会消化系早癌内镜诊断与治疗协作组,中华医学会消化病学分会消化道肿瘤协作组,中华医学会消化病学分会消化病理学组.中国早期食管鳞状细胞癌及癌前病变筛查与诊治共识(2015年·北京)[J].中国实用内科杂志,2016,36(1):20~33.
[4] 中国临床肿瘤学会指南工作委员会.食管癌诊疗指南(2020版)[M].北京:人民卫生出版社,2020.
[5] Toyokawa T,Kubo N,Tamura T,et al.Platelet to lymphocyte ratio is a predict-ive marker of prognosis and therapeutic effect of postoperative chemothera-py in non-metastatic esophageal squamous cell carcinoma[J].Clin Chim Acta,2018,479:160~165.
[6] Yang J,Liu Y,Li B,et al.Prognostic significance of tumor length in patientswith esophageal cancer undergoing radical resection:a PRISMA-compliant me-ta-analysis[J].Medicine (Baltimore),2019,98(14):e15029.
[7] Rice TW,Ishwaran H,Hofstetter WL,et al.Recommendations for pathologic stag-ing (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals[J].Dis Esophagus,2016,29(8):897~905.
[8] Arigami T,Uchikado Y,Omoto I,et al.Primary tumor score based on tumor depthand length predicts prognosis in esophageal squamous cell carcinoma[J].Ant-icancer Res,2018,38(9):5447~5452.
[9] Sun Y,Zhang L.The clinical use of pretreatment NLR,PLR,and LMR in patients with esophageal squamous cell carcinoma:evidence from a meta-analysis[J]. Cancer Manag Res,2018,10:6167~6179.
[10] Kitagawa Y,Uno T,Oyama T,et al.Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society:Part 1[J].Esophagus,2019,16(1):1~24.
[11] Mashimo H,Gordon SR,Singh SK.Advanced endoscopic imaging for detecting and guiding therapy of early neoplasias of the esophagus[J].Ann N Y Acad Sci,2020,1482(1):61~76.